- 
                        The Centers for Disease Control and Prevention recently released new guidelines surrounding intrauterine device pain. A local doctor says talking about this with a medical professional is the key to a smoother procedure.
 - 
                        There's often a spike in respiratory viruses and other illnesses as children head back into the classroom. A local infectious disease specialist is urging parents to take preventive measures despite vaccine fatigue.
 - 
                        An eight-year-old girl dealing with a congenital heart condition cut the ribbon at Lehigh Valley Zoo to announce the American Heart Association of Greater Lehigh Valley and Berks County annual Heart Walk in September.
 - 
                        “A Community Conversation: Path to a Healthier Valley” starts at 6 p.m. Thursday, Aug. 22, and can also be watched streaming online on PBS39.org. The hourlong program touches on efforts to make the region a so-called "Blue Zone."
 - 
                        The health of the Lehigh Valley is improving, but there is room to grow according to health experts. They are sharing where residents need to do better and how to get there.
 - 
                        A cheaper, needle-free alternative to the EpiPen will soon be available following FDA approval. Neffy is a epinephrine nasal spray that can treat anaphylaxis.
 - 
                        The CDC has reported over 400 cases of salmonella across 31 states and the District of Columbia, including 60 cases in Pennsylvania.
 - 
                        Lehigh Valley Health Network and Jefferson Health merged to become a regional provider on August 1st. The law firm that helped seal the deal explains what went into making that happen.
 - 
                        The American Red Cross and Miller-Keystone Blood Bank are urging people to give blood to avoid a critically low situation. A summer slump and severe weather has impacted donations.
 - 
                        Lehigh Valley Health Network is launching a clinical trial for a pancreatic cancer vaccine. A handful of hospitals across the country are part of the second phase of the study.